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Abstract-Studies of hypervitaminosis A in animals and anecdotal reports of accidental 
vitamin A poisoning in humans suggest impairment of bone remodeling and increased 
numbers of fractures. Because of the widespread use of high-dose vitamin A supplements 
which may produce subclinical hypervitaminosis associated with decreased bone mass 
and increased risk of fracture, we studied the relationship between current vitamin A 
supplement use, serum retinol levels, radial bone mass and fracture history in a 
geographically-defined population of 246 postmenopausal women, 55-80 years of age. 
More than 36% of this population used a vitamin A supplement with 8% of these 
consuming an amount in excess of 2000 retinol equivalents (RE)/day. Serum retinol 
was measured using high-pressure liquid chromatography and radial bone mass was 
measured using single photon absorptiometry. After controlling for age, current 
estrogen replacement, and current thiazide antihypertensive use, we observed no 
statistically significant relationship between vitamin A supplement use or serum retinol 
with radial bone mass or fractures. 
Vitamin A Retinol Dietary supplements Bone mass Fractures 
INTRODUCTION 
Vitamin A can be toxic to a variety of tissues, 
including bone [I]. Animals fed high doses of 
the substance acquire systematic changes in 
growing and mature bones, including selective 
absorption, cortical thinning and increased 
numbers of fractures [2]. Clinical studies of the 
skeletal effects of vitamin A, such as in the 
treatment of dermatologic conditions, have sug- 
gested an association with hyperostosis, hyper- 
calcemia and increased bone resorption [3-91. 
Because vitamin A supplements are widely 
available and community consumption has been 
documented [lo-l 31, investigation of the effects 
of vitamin A on bone status and health seems 
to be required. In a population of Japanese- 
*Supported by Contract No. NOI-AG-02106. 
tAuthor for correspondence. 
Americans, dietary vitamin A, obtained by the 
24-hour recall method, was positively associated 
with increased bone density [14]. In a second 
study, there was a positive relationship between 
vitamin A and rate of humeral bone loss, and 
substantial loss in a woman consuming about 
4000 retinol equivalents (RE)/day 1151. In a 
previous cross-sectional study of rural Iowa 
women, we found that vitamin A intake from 
diet and supplements was inversely associated 
with radial bone mass, but the relationship was 
small and not significant [16]. 
We are not aware of any clinical or exper- 
imental studies of vitamin A and bone mass, 
and none of the population studies noted above 
included a biochemical marker of vitamin A 
intake. Here we report findings from a different 
population of Iowa women, exploring the im- 
pact of blood vitamin A levels as well as that 
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from dietary supplement sources on radial bone Our precision, described with the coefficient of 
mass. variation, is approx. 2%. 
It is the purpose of this paper to undertake 
the following: 
-to test the hypothesis that vitamin A 
supplementation, or elevated retinol as a 
biologic marker of vitamin A, may be 
associated with decreased bone mass in 
postmenopausal women, 
-to test the hypothesis that levels of serum 
retinol or vitamin A from supplement may 
be associated with an increase in the report 
of fracture in postmenopausal women. 
METHODS 
All postmenopausal women living in a geo- 
graphically-defined small rural community in 
northwest Iowa were invited to participate in a 
study of bone mass. Those women who were 
studied reported no disease directly associated 
with bone mass, had lived in the defined com- 
munity at least 5 years, were sufficiently ambu- 
latory to climb three stairs, were less than 81 
years of age and were of Northern European 
heritage. 
Fractures were reported in an interview 
according to site and year of fracture. For data 
analysis, fractures were tallied unless associated 
with a known traumatic event such as vehicular 
accident. Fracture status was classified three 
ways. First, as a dichotomous variable, women 
were categorized as ever having a fracture vs 
never having a fracture. Second, as a trichoto- 
mous variable, women were classified as having 
fractures of the spine, hip, and wrist vs fractures 
at other sites vs no reported fractures. Third, the 
trichotomous variable was restricted to those 
women who reported their fracture occurring in 
the 10 years prior to study. Fractures of the 
spine, hip and wrist are commonly associated 
with osteoporosis. The fracture classification 
limited to the previous 10 years was selected to 
provide measures which may be more contem- 
porary with supplement practice and retinol 
values. 
Assessment of vitamin A 
The biochemical marker selected to represent 
A census of all women in the area was 
developed by itemizing all residential properties 
within the city limits and telephoning each 
property to determine if eligible women were 
associated with the property. Any property 
without phone access was visited by a member 
of the survey team. There were 299 post- 
menopausal women who were eligible to par- 
ticipate; of those, 263 (88%) consented to 
interview and bone mass measurement. Both 
blood sample and bone mass measures were 
available for 82% (n = 246) of the 299 eligible 
women. Women who refused participation or 
blood drawing were more likely to be unmarried 
and to have fewer years of education. They did 
not report that they perceived themselves to 
have less favorable health status than other 
women their age. 
Bone mass meakement and fracture 
Bone mass was measured with a Norland 278 
Photon absorptiometer (Norland Corporation; 
Fort Atkinson, Wise.) which uses the system 
originated by Cameron [17, 181. Bone mass 
was measured at a site one-third the distance 
between the styloid process and the olecranon. 
Bone mass is expressed as the amount of 
bone mineral (g), to the bone width (cm). 
serum vitamin A was retinol. Vitamin A is a 
non-specific term for a number of different 
molecular forms; however, retinol represents 
an important end-product reflecting enzymatic 
conversion of b-carotene, retinyl esters and 
retinal [ 19,201. Blood for serum retinol determi- 
nation was drawn by venipuncture. Serum was 
drawn off the centrifuged blood, aliquoted, and 
stored in vials which were frozen at -20°C 
during field collection up to 63 days and then 
at -70°C until analysis, which occurred less 
than 6 months following collection. The serum 
was protected from light oxidation and was 
not thawed prior to analysis. Retinol levels 
were quantified by high pressure liquid chro- 
matography in the vitamin A reference labora- 
tory of Dr James Olson, Iowa State University. 
Retinol was selected as the most suitable bio- 
chemical measure to reflect diet and supple- 
mentation practice; it is not intended to reflect 
dietary consumption within a previous 24-hour 
period [ 191. 
Nutrient intake was quantified from two 
sources: a nutritional supplements interview and 
24-hour food recall. The interviewer observed 
labels of currently used nutrition preparations, 
including vitamin, mineral and protein supple- 
ments, and recorded dose and chemical compo- 
sition. The participant was asked to recall the 
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number, frequency and duration of use of each current medications included any thiazide 
preparation. derivative. 
Interviewers were trained to elicit a 24-hour 
food recall. The interviewer showed color 
photographs of food to enhance the par- 
ticipant’s recall of serving sizes which were 
reported in common household units. Two 
different interviewers coded each recall and a 
nutritionist (MFS) resolved coding differences. 
Nutrient values were assigned to the coded 
foods using USDA tape No. 456 which pro- 
vided nutrient information for 20 nutrients. This 
food table did not characterize the form of the 
biologic activity of the vitamin A. 
Participants were measured for height, 
weight, midarm circumference, and triceps 
skinfolds. Humeral muscle area was calculated 
from these data and used as the variable to 
reflect body size [2 11. 
Informed consent was obtained in accord 
with the ethical standards of the Committee on 
Human Experimentation. 
Statistical analyses 
All nutrient values were transformed to com- 
mon logarithms to normalize their distributions 
and the normalized values used in data analysis. 
Other variables 
Interviewers questioned participants about 
factors which might affect bone mineralization 
including demographic information, repro- 
ductive history, menopausal history, medical 
history, activity, sunlight exposure, and use of 
tobacco and alcohol products. For purposes 
of analysis, women were defined as post- 
menopausal if they reported no longer having 
menses because of surgery or natural history. 
If menopause was uncertain, a woman was 
classified as postmenopausal if she had not 
experienced menses in the 3 months prior to 
bone mass measurement, was not pregnant or 
lactating and was in the age range where 
menopause was likely to occur. 
Normality of variable distribution was 
evaluated with univariate analysis, and those 
variables whose distribution was highly skewed 
were either categorized or transformed. Associ- 
ations between vitamin A levels and bone mass 
were tested with simple linear and multiple 
regression analysis [22]. Logistic regression 
analyses were used to test whether diet vitamin 
A, supplemental.vitamin A or serum retinol was 
associated with fracture [23]. 
FINDINGS 
Interviewers observed current medication 
containers for drug name, dose, and queried 
respondents about frequency of use. Drugs were 
coded to be characterized for both intended 
therapeutic use as well as composition. Women 
were classified as users of thiazides if their 
Mean values for serum retinol, supplement 
vitamin A, and dietary vitamin A are shown in 
Table 1 according to participant’s chronological 
age, displayed in 5-year age groupings. Because 
of skewed distributions, dietary vitamin A in- 
take, supplemental vitamin A intake and serum 
retinol are presented in Figs 1, 2 and 3 as 
median intakes and percentile distributions. 
Percentile distributions are limited to values 
between the 10th and 90th percentiles as limited 
sample sizes generate instability beyond these 
values. The correlation between vitamin A 
supplement intake estimate and retinol levels 
was 0.14, p < 0.03; the correlation between 
Table I. Mean values (&SD) of serum retinol, dietary vitamin A, and 
supplement vitamin A among 246 postmenopausal women according to 
5-year age groupings 
Supplement Dietary 
Retinol vitamin A vitamin A 
Age group n (mmol/l) (RE)* (RE)* 
246 1.60 f 0.54 309 i 537 594+681 
4044 10 1.38 + 0.49 180 &- 423 415 * 193 
4549 14 1.53 * 0.49 214+425 449 + 223 
50-54 36 I .52 + 0.45 389 &- 741 685 + 549 
55-59 28 1.60 f 0.48 285 k 638 379 f 493 





1.61 z 0.54 41 I 7 541 509 z 492 
1.63 + 0.55 268 + 449 655 & 739 
1.69 f 0.56 232 f 382 843 f 1100 
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retinol and dietary food intake estimate was 
0.02, p < 0.70. 
Characteristics of supplement users 
In this population of women, 36% (n = 89) 
reported using a supplement containing vitamin 
A on a continuing basis within the previous 
year. Of those supplement users, 54% had aver- 
age daily vitamin A supplement intakes of less 
than 1000 RE; 38% had intakes between 1000 
and 2000 RE; and 8% had average daily intakes 
of vitamin A from supplement greater than 2000 
RE, a level which is 2.5 times the Recommended 
Dietary Allowance [23]. 
There was a statistically significant relation- 
ship in mean serum retinol levels between vita- 
min A supplement users (1.69 & 0.52 mmol/l) 
vs non-users (1.55 + 0.52 mmol/l, p < 0.03) (see 
Table 2). 
Potential confounders 
Our previous studies suggested that age, 
humeral muscle area, thiazide medication use, 
and perimenopausal estrogen use are significant 
predictors of bone mass in this population [16]. 
Another study had suggested that smoking is 
associated with bone mass [24]. We wanted to 
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Fig. 3. Percentile distribution of dietary intake of vitamin A 
as reported by 246 post menopausal women living in a 
geographically defined area. 
determine which factors related to bone mass 
might also be related to vitamin A supple- 
ment use (Table 2). There was no statistically 
significant difference in potentially confounding 
factors according to supplement use. 
We also examined retinol level relative to 
age, current thiazide use, current estrogen use, 
muscle area, and smoking behavior. Serum 
retinol levels increased with age (B = 0.19; 
r = 0.12, p < 0.05). Persons who had smoked 
more than 9000 packs of cigarettes in their 
lifetime, which represents a median value for 
smokers in this population, had significantly 
greater serum retinol levels than those 
Table 2. Selected characteristics comparing vitamin A supplement users to non- 
supplement users in a geographically defined population of post-menopausal women 
Supplement users Non-users 
Mean&SD Mean f SD 
Number 89 I57 
Age (yr) 63.7 + 9 62.9 f IO NS 
Quetelet Index (wt/ht’) 27.3 f 6.2 27.0 & 5.7 NS 
Serum retinol (mmol/l) 1.69 + 0.52 I.55 + 0.52 p c 0.03 
Dietary vitamin A (RE) 679 f 756 578 f 820 NS 
Radial bone mass (mg/cm’) 0.610 f 0.1 I 0.637 f 0.12 NS 
Percent smokers 26% 19% NS 
Percent current estrogen users 6% 9% NS 
Percent current thiazide users 18% 25% NS 
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who reported no smoking (1.90 rt 0.11 mmol/l 
(SEM) vs 1.56 + 0.04 mmol/l,p < 0.0001). After 
controlling for age, this relationship was still 
statistically significant (p < 0.01). 
Thiazide medication use was found to be 
associated with serum retinol levels. Women 
currently using thiazide antihypertensive medi- 
cation had consistently higher mean serum 
retinol values than did non-users. After adjust- 
ing for age, the mean value (f SEM) of retinol 
in women using thiazide was 1.77 f 0.07 mmol/l 
vs 1.55 f 0.04 mmol/l for women not using 
thiazide medication (p < 0.008). Women who 
used thiazide medications were more likely to 
use supplements, though the difference was 
not statistically significant. Dietary intakes of 
vitamin A were not different in women who 
used thiazide medications vs those who did not. 
Supplement use, retinol and bone mass 
There was no relationship observed between 
radial bone mass and supplement intake of 
vitamin A irrespective of whether the dietary 
source was supplement alone or diet and supple- 
ment amounts combined together, after adjust- 
ing for predictors of bone mass including age. 
There was no statistically significant relation- 
ship between serum retinol and bone mass 
(r = -0.04, n = 246). There was no observed 
relationship between bone mass and serum 
retinol level after adjusting for factors associ- 
ated with bone mass when the population was 
stratified according to vitamin A supplement 
use. When retinol values were divided into 
tertiles and mean bone mass of women in the 
upper tertile compared with mean bone mass of 
women in the lower tertile of retinol values, no 
significant relationship between bone mass was 
observed when the comparison included adjust- 
ment for age, muscle area, and thiazide use. 
Supplement use, retinol and fracture 
In this population, there were 98 (40%) 
women who reported ever having a fracture, 56 
(23%) who reported an atraumatic fracture of 
the hip, ribs, spine or wrist postmenopausally, 
3 1 (13%) who reported any fracture in the past 
10 years, and 21 (8.5%) who reported fracture 
of the hip, spine, ribs, or wrist in the past 10 
years. We observed no increased probability of 
observing a fracture associated with the current 
retinol level irrespective of fracture category. 
Similarly, we observed no increased probability 




The use of vitamin A supplements is increas- 
ingly characteristic of the American population 
with doses in some instances approaching levels 
which may be toxic. Up to 60% of persons are 
presently using supplement, according to some 
surveys [12,13]. In a study conducted by the 
Food and Drug Administration in the early 
1980s [lo], more than 4% of vitamin A users 
were taking at least 5 times the Recommended 
Dietary Allowance of vitamin A [25], a per- 
centage observed in our own studies [I 11. This 
practice is likely to continue as research relating 
vitamin A to cancer and skin aging are publi- 
cized [26,27] and access to vitamin A is within 
the domain of personal decision-making. Yet 
there is limited exploration of bone health in an 
aging population of women who are using vita- 
min A supplement preparations in quantities 
which may approach toxicity. 
This study describes the association between 
serum retinol levels, vitamin A supplement use 
and indices of bone status in a geographically- 
defined population. After controlling for other 
factors which predict different levels of bone 
mass, we observed that neither the use of vita- 
min A supplements in the amount and fre- 
quency consumed in this population nor serum 
retinol are significantly associated with a 
measure of radial bone mass in postmenopausal 
women. Furthermore, there was no increased 
probability of fracture among those women 
using supplements or with serum retinol level. 
The impact of toxic doses of vitamin A on 
bone mass has been described in three different 
situations: accidental overdose from supplement 
use, treatment for skin disorders, and in chronic 
renal failure. In anecdotal reports of patients 
being treated for dermatologic disorders, skel- 
etal hyperostosis, increased resorption, hyper- 
calcemia and renal calculi have been observed 
[3-9,281. In patients with chronic renal prob- 
lems, plasma concentrations of total vitamin A 
and retinol-binding protein are increased but 
the molar ratio of vitamin A to retinol-binding 
protein are lower than in controls. There are 
inconsistent observations as to evidence of 
hypercalcemia and osteodystrophy in renal 
patients; Cundy et al. and Farrington et al. 
[29,30] advise caution in prescribing the use of 
vitamin A supplements to these patients. 
In animal and tissue culture studies, hyper- 
vitaminosis A leads to reduction in bone mass 
and characteristics of increased bone resorption 
[31-381. Clark and Seawright et al. [39,40] 
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described inappropriate architecture and change recruiting study populations who are not 
in morphology of kitten bone, and Clark [41] clinically ill [46]. 
observed that whereas fractures occur more Bone status evolves as a long-term process 
frequently in the young, rarefaction is more whereas this study was able to compare bone 
frequently observed in the adult. status with current supplement practice and 
It is important to recognize that this single-time biochemical measure. Though this 
study does not test the hypothesis that hyper- is a limitation, if an association is strong, cur- 
vitaminosis A from vitamin A supplement is rent practice relationships might be observed, 
negatively related to all aspects of bone health. as is the case with estrogen supplementation, 
This study has sufficient sample size and power and provide motivation for studies of the 
to test the overall association of supplement relationship prospectively. 
with bone mass, but not to test the association Though the present study suggested no 
of doses exceeding 2000 RE per day, unless relationship between supplement use, serum 
differences generated in bone mass are extra- retinol and radial bone mass, an awareness 
ordinarily large. Other elements associated with of the possible implications of unsupervised 
bone health not studied included bone mass ingestion of large doses of vitamin A should 
at multiple sites, change in bone morphology remain a concern of health professionals until 
and joint changes. additional studies support the observation of 
This study also does not address the issue no effect. 
of whether dietary vitamin A is associated 
with levels of bone mass. The intra- and inter- 
personal variability associated with estimates of 
vitamin A intake from food is great. To effect- 
ively estimate intake requires multiple days of 
recalls and large sample sizes [42,43]. We could 
not address the issue of vitamin A chemical 
configuration. Vitamin A represents a group of 
retinoid and carotenoid compounds, including 
natural and synthetic forms, which have vary- 
ing degrees of biologic activity. There was 
insufficient data to attribute specific biologic 
activity to the food consumed by this popu- 
lation. Characterizing relationships with less 
definitively defined products may bias the 
finding toward the null. 
The study involves radial bone mass measure- 
ment using single photon densitometry. Though 
there is much debate as to the need to measure 
bone at a specific site to characterize fracture 
risk at that site [44], and bone mass measure- 
ment of the spine and hip are now available 
using dual photon or dual X-ray densitometry, 
measurement of the radius, in our view, remains 
an important research tool for population 
studies. Recently published work has shown, 
prospectively, that radial bone mass measure- 
ments are highly predictive of risk for fracture 
[45]. Bone mass measurement using the single 
photon densitometer can be done with greater 
precision than the dual photon densitometer 
(approx. 2 vs 4%) reducing the sample size 
needed to identify differences if they exist. There 
is less exposure in the single photon densi- 
tometer as compared with a dual energy densi- 
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